Publications
Virtual screening as a strategy for the identification of xenobiotics disrupting corticosteroid action.
Nashev LG, Vuorinen A, Praxmarer L, Chantong B, Cereghetti D, Winiger R, Schuster D, Odermatt A
PloS one, 12 Oct 2012
Transcriptional regulation of CYP2C19 and its role in altered enzyme activity
Uppugunduri CR, Daali Y, Desmeules J, Dayer P, Krajinovic M, Ansari M
Current drug metabolism, 1 Oct 2012
Transcriptional regulation of CYP2C19 and its role in altered enzyme activity
Uppugunduri CR, Daali Y, Desmeules J, Dayer P, Krajinovic M, Ansari M
Current drug metabolism, 1 Oct 2012
Hepatic fat loss in advanced nonalcoholic steatohepatitis: Are alterations in serum adiponectin the cause?
van der Poorten D, Samer CF, Ramezani-Moghadam M, Coulter S, Kacevska M, Schrijnders D, Wu LE, McLeod D, Bugianesi E, Komuta M, Roskams T, Liddle C, Hebbard L, George J
Hepatology : official journal of the American Association for the Study of Liver Diseases, 19 Sep 2012
Hepatic fat loss in advanced nonalcoholic steatohepatitis: Are alterations in serum adiponectin the cause?
van der Poorten D, Samer CF, Ramezani-Moghadam M, Coulter S, Kacevska M, Schrijnders D, Wu LE, McLeod D, Bugianesi E, Komuta M, Roskams T, Liddle C, Hebbard L, George J
Hepatology : official journal of the American Association for the Study of Liver Diseases, 19 Sep 2012
Pharmacokinetic interaction between prasugrel and ritonavir in healthy volunteers.
Ancrenaz V, Déglon J, Samer C, Staub C, Dayer P, Daali Y, Desmeules J
Basic & clinical pharmacology & toxicology, 21 Aug 2012
Pharmacokinetic interaction between prasugrel and ritonavir in healthy volunteers.
Ancrenaz V, Déglon J, Samer C, Staub C, Dayer P, Daali Y, Desmeules J
Basic & clinical pharmacology & toxicology, 21 Aug 2012
Analgesics in patients with hepatic impairment: pharmacology and clinical implications
Bosilkovska M, Walder B, Besson M, Daali Y, Desmeules J
Drugs, 20 Aug 2012
Analgesics in patients with hepatic impairment: pharmacology and clinical implications
Bosilkovska M, Walder B, Besson M, Daali Y, Desmeules J
Drugs, 20 Aug 2012
The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro.
Ancrenaz V, Desmeules J, James R, Fontana P, Reny JL, Dayer P, Daali Y
British Journal of Pharmacology © 2012, 1 Aug 2012